Johns Hopkins University is backing a new effort to support drug discovery research that could lead to new companies.
The Baltimore university and New York-based investment firm Deerfield Management created Bluefield Innovations to provide funding for early-stage therapeutic research at JHU.
The venture is providing $65 million for research over five years, with the potential for more funding to back research that shows “strong commercial potential,” according to a release.
READ FULL ARTICLE HERE
